Roche Raises 2019 Sales View After 1Q Sales Beat
April 17 2019 - 6:04AM
Dow Jones News
(Adds details on sales growth, share price)
By Donato Paolo Mancini and Denise Roland
Roche Holding AG (ROG.EB) has raised its outlook for the year
after reporting strong sales growth in the first quarter.
The Swiss healthcare giant said Wednesday that it now expects
sales and core earnings per share to grow by a mid-single-digit
percentage in 2019, at constant currencies. It had previously
expected growth in the low-to-mid single-digit range.
Sales for the three months to March 31 rose 9% to 14.83 billion
Swiss francs ($14.73 billion), beating analysts' expectations of
CHF14.23 billion--a consensus estimate compiled by FactSet.
Accounting for currency fluctuations, sales increased 8%.
The company doesn't report earnings at the quarterly stage.
Sales growth was driven by multiple sclerosis medicine Ocrevus,
cancer drugs Perjeta and Tecentriq, and hemophilia treatment
Hemlibra.
The strong sales of those four medicines offset a decline in
Roche bestsellers Herceptin and Rituxan, which now face competition
in Europe from lower-cost copies known as biosimilars. Roche
expects competition to intensify later this year, with the likely
launch of biosimilars of those two drugs, plus another top-seller
Avastin, in the U.S.
Overall, sales at Roche's pharmaceuticals business increased 10%
at constant currencies to CHF11.9 billion. Revenue for the smaller
diagnostics business rose 1% to CHF2.9 billion.
Analysts said the first-quarter figures were a significant
beat.
"This strong 1Q performance underscores our confidence in Roche
as the top pick in EU large-cap pharma," Jefferies wrote a research
note.
Zurich-listed shares in Roche struggled for direction in
midmorning trading. Initial enthusiasm, which saw shares climb 1.9%
after the bell, later cooled off, with shares sliding 0.5%. They
were last flat at CHF269.
Write to Donato Paolo Mancini at
donatopaolo.mancini@dowjones.com; @donatopmancini and Denise Roland
at denise.roland@wsj.com
(END) Dow Jones Newswires
April 17, 2019 05:49 ET (09:49 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024